مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

540
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

Non-Alcoholic Fatty Liver Disease

Pages

  203-212

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease worldwide. Recent studies have shown that NAFLD occurs in both sexes, at any age, and in any economic situation. In Iran, the prevalence of NAFLD has been reported between 2. 09% and 2. 9%. The most common cause of the disease is insulin resistance, along with obesity and cardiovascular disease. The true incidence and prevalence of NAFLD can be difficult to determine due to the variability in the definition of the disease. Clinical symptoms of fatty liver disease are often unreliable and non-specific, and diagnostic methods include biochemical markers of radiological imaging accompanied by liver biopsy. The most commonly used treatments are diet, exercise, and pharmacological and surgical treatment of the liver. In this article, after the introduction of the disease and symptoms, epidemiology, etiology, complications, laboratory findings, differential diagnoses, treatment, and follow-up are described. Diagnostic methods of this disease include laboratory tests, biomarkers, imaging studies such as ultrasonography, computed tomography, magnetic resonance imaging, and fibroscopy, and biopsy sampling. Interactions such as lifestyle changes, weight loss, insulin resistance management, lipid lowering factors, decrease weight, drugs, surgery, and liver transplantation are effective treatments. Management of NAFLD and early and correct diagnosis and treatment of this disease can reduce the mortality and morbidity of the disease.

Cites

References

  • No record.
  • Cite

    APA: Copy

    HORMATI, AHMAD, SHAKERI, MANSOUREH, IRANIKHAH, ABOLFAZL, Afifian, Mahboobe, & SARKESHIKIAN, SEYED SAEED. (2019). Non-Alcoholic Fatty Liver Disease. GOVARESH JOURNAL, 23(4 ), 203-212. SID. https://sid.ir/paper/409605/en

    Vancouver: Copy

    HORMATI AHMAD, SHAKERI MANSOUREH, IRANIKHAH ABOLFAZL, Afifian Mahboobe, SARKESHIKIAN SEYED SAEED. Non-Alcoholic Fatty Liver Disease. GOVARESH JOURNAL[Internet]. 2019;23(4 ):203-212. Available from: https://sid.ir/paper/409605/en

    IEEE: Copy

    AHMAD HORMATI, MANSOUREH SHAKERI, ABOLFAZL IRANIKHAH, Mahboobe Afifian, and SEYED SAEED SARKESHIKIAN, “Non-Alcoholic Fatty Liver Disease,” GOVARESH JOURNAL, vol. 23, no. 4 , pp. 203–212, 2019, [Online]. Available: https://sid.ir/paper/409605/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button